23andMe closes out 2020 with $82.5M in funding
DNA testing company 23andMe raised $82.5 million in funding, according to a recent filing. Earlier this year, decreased sales of tests kits led to cuts at the company and its competitors.
DNA testing company 23andMe raised $82.5 million in funding, according to a recent filing. Earlier this year, decreased sales of tests kits led to cuts at the company and its competitors.
Judges picked TrialSpark as the winner on the life sciences track of the pitch competition at MedCity's virtual precision medicine conference. While the company is focused on improving clinical trials for others, it hopes eventually to bring drugs of its own to market.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company sources product candidates from academic and commercial research and then launches subsidiary companies to develop them.
The company, Maven, raised funding from investors including Sequoia Capital, Oak HC/FT, 14W, Female Founders Fund and Spring Mountain Capital.
Through its popular consumer portal, the Silicon Valley company has recruited thousands of study participants to identify genetic determinants of depression, heart disease, cancer, immunological disorders and skin diseases.
Telcare, which has developed mobile applications to monitor blood glucose levels for diabetics, has raised $32.5 million in a Series C round. The Bethesda-based digital health company, which also developed a HIPAA-compliant cloud for data storage, was founded in 2009. Funding was led by Norwest Venture Partners, with additional help from Mosaic Health Solutions and […]
Newly inaugurated Gov. John Kasich has appointed friend, campaign contributor and Sequoia Capital partner Mark Kvamme as the interim director of the Ohio Department of Development.